SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-001839
Filing Date
2021-02-25
Accepted
2021-02-25 16:29:30
Documents
96
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cara-20201231x10k.htm   iXBRL 10-K 3535029
2 EX-4.4 cara-20201231xex4d4.htm EX-4.4 163615
3 EX-10.21 cara-20201231xex10d21.htm EX-10.21 387857
4 EX-23.1 cara-20201231xex23d1.htm EX-23.1 12170
5 EX-31.1 cara-20201231xex31d1.htm EX-31.1 11507
6 EX-31.2 cara-20201231xex31d2.htm EX-31.2 11671
7 EX-32.1 cara-20201231xex32d1.htm EX-32.1 10332
8 GRAPHIC cara-20201231x10k004.jpg GRAPHIC 30937
  Complete submission text file 0001558370-21-001839.txt   14196287

Data Files

Seq Description Document Type Size
9 EX-101.SCH cara-20201231.xsd EX-101.SCH 78010
10 EX-101.CAL cara-20201231_cal.xml EX-101.CAL 78732
11 EX-101.DEF cara-20201231_def.xml EX-101.DEF 377186
12 EX-101.LAB cara-20201231_lab.xml EX-101.LAB 726351
13 EX-101.PRE cara-20201231_pre.xml EX-101.PRE 617997
14 EXTRACTED XBRL INSTANCE DOCUMENT cara-20201231x10k_htm.xml XML 2458732
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36279 | Film No.: 21680801
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences